连续胺注作为抑郁症住院护理的辅助疗法:KARMA-Dep 2随机临床试验
Ana Jelovac1, Cathal McCaffrey1, Masashi Terao1
1Department of Psychiatry, School of Medicine, Trinity College Dublin, St Patrick's University Hospital, Dublin, Ireland.
JAMA psychiatry
|October 22, 2025
概括
在住院患者的重度抑郁症中,连续注入胺并没有比米达佐拉姆更有效. 这项试验在减少抑郁症状或改善生活质量方面没有发现显著差异.
科学领域:
- 精神病学是一个精神病学.
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
背景情况:
- 连续胺注射越来越多地用于重大抑郁症的非标签.
- 来自安慰剂对照试验的证据关于胺的疗效和安全性是有限的.
研究的目的:
- 为了比较连续胺注射与米达佐拉姆的抗抑郁药疗效,安全性,耐受性,成本效益和生活质量.
- 评估胺作为常规住院精神病治疗的辅助剂.
主要方法:
- 一个双盲的,随机的,米达佐拉姆受控的实证试验 (KARMA-Dep 2) 涉及住院成人有重大抑郁症发作.
- 参与者每周两次接受多达8次胺 (0.5毫克/千克) 或米达胺 (0.045毫克/千克) 的输液,并接受通常的护理,随访6个月.
主要成果:
- 在治疗结束时,胺基和米达佐拉姆组之间抑郁症症状严重程度 (MADRS评分) 没有显著差异.
- 在自我报告的抑郁症,安全性,耐受性,认知,成本效益或生活质量方面,没有观察到群体之间的显著差异.
- 大多数参与者和评价者正确猜测了他们的治疗分配,这表明缺乏盲目的有效性.
结论:
- 连续的辅助胺注射并没有比连续的米达佐拉姆注射更有效,对于接受标准精神病治疗的住院抑郁症患者.
- 研究结果表明,在这种临床环境中,胺可能不会比米达佐拉姆更有优势.
- 需要进一步的研究来澄清胺在管理重大抑郁症发作中的作用.
相关概念视频
Electroconvulsive Therapy
771
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
771
Parenteral Anesthetics: Overview
540
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
540
Depressive Disorders: MDD and Dysthymia
547
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
547
Depressive Disorders: Etiology
406
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
406
Sedatives and Hypnotics: Overview
1.3K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.3K
Depression: Overview
735
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
735


